Ireland’s Ageing Population Will Double Homecare Needs - Data Highlights Planning Required...
The company is preparing for commercial rollout in Europe, where France has emerged as the single largest opportunity, given its high contraceptive usage yet limited permanent alternatives...
H2 Global Group, together with its subsidiary H2 Medical Technologies, has entered a decisive growth stage following strong recognition at LSI Europe 2025 in London...
Philips’ new Rembra RT and Areta RT systems are designed to make cancer treatment planning faster and more accurate...
Femasys leverages Kebomed’s pan-European distribution strength to drive the adoption of FemBloc permanent birth control in France and Benelux, unlocking significant market access...
RefluxStop is very well positioned to fill the upcoming treatment gap as our main device competitor exits the European market...
SiBionics' next-generation devices, the GS3 Continuous Glucose Monitoring (CGM) system and the KS3 Continuous Ketone Monitoring (CKM) device, became focal points, drawing considerable attention from attendees...
The COHERENT-AF trial will enrol up to 360 patients across clinical sites in the United States and Europe...
This next-generation device, which builds on the proven RECELL System, represents a leap forward in the treatment of burns, trauma, and surgical wounds by streamlining usability, reducing training requirements, and improving delivery consistency...
AVITA Medical will begin commercialisation of RECELL GO in select European countries, including Germany, Italy, and the United Kingdom ...
